Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

tDCS over DLPFC vs DMPFC for Depression

Official title: A Comparative Study of the Clinical Efficacy of Transcranial Direct Current Stimulation Targeting the DLPFC Versus DMPFC in the Treatment of Depression

Run by The Second Hospital of Anhui Medical University · NCT07500064 · Data updated 2026-11-12

This study tests whether applying mild brain stimulation to the dorsolateral or dorsomedial prefrontal cortex can help people with depression feel better.

More Depression trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment50 (estimated)
SponsorThe Second Hospital of Anhui Medical University
Academic / other
Locations1 site (Hefei, Anhui)
StatusRecruiting
StartedMarch 30, 2026
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedMay 19, 2026
Trial IDNCT07500064 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 with DSM-5 diagnosed depression who can participate in tDCS and provide informed consent.

Probably not a fit

Individuals with contraindications to tDCS, comorbid severe neuropsychiatric illnesses, or implants/ferromagnetic devices in the head may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, double-blind study compares two tDCS target regions—the DLPFC and the DMPFC—in inpatients with depression. Participants receive non-invasive brain stimulation using a simple, low-cost approach and are assigned to one of the target sites to see which approach offers greater mood improvement. The trial emphasizes safety, tolerability, and effects on emotional regulation as assessed by neuropsychological scales. Conducted at The Second Hospital of Anhui Medical University, it focuses on adults aged 18–65 meeting DSM-5 criteria for depression. The design aims to clarify whether targeting the DLPFC or DMPFC yields differential benefits for emotional regulation in depression.

Why it matters

Potential benefit: If successful, this approach could identify a more effective, low-cost non-invasive treatment option for improving mood in depression.

How similar studies have gone: Previous non-invasive brain stimulation studies with tDCS have shown promise in depression, supporting further exploration of targeted regions like DLPFC and DMPFC.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* The diagnosis meets the criteria for depression outlined in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
* Age between 18 and 65 years.
* Education level exceeding 5 years, with no significant hearing or visual impairments.
* Voluntary signing of informed consent and ability to cooperate with general demographic data collection and neuropsychological scale testing.

Exclusion Criteria:

* Age under 18 or over 65.
* Patients with neurological disorders such as epilepsy or severe physical illnesses.
* Patients with comorbid neuropsychiatric disorders, such as schizophrenia or obsessive-compulsive disorder.
* Patients unable to undergo tDCS treatment for any reason, including presence of ferromagnetic metal in the head or implanted medical devices in the head/neck region.
* Pregnant or lactating women.

Where it's running

  • The Second Affiliated Hospital of Anhui Medical University
    Hefei, Anhui, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.